F2RL1 and cancer: This effect might be especially beneficial as TF+EVs not only activate the coagulation system but also have migration-inducing effects on PAR2-expressing cancer cells (Ender et al. 2019; Gamperl et al. 2016; Gieseler et al. 2013).